தத்தா மேகே நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தத்தா மேகே நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தத்தா மேகே நிறுவனம் Today - Breaking & Trending Today

Study backs Ayurvedic drug Ayush 64 in for treatment of mild to moderate Covid-19 infection


Industry > Industry monitor > Healthcare
29 April 2021
Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care.
Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collaborated for robust multi-centre clinical trials to evaluate the safety and efficacy of Ayush 64 in the management of mild to moderate Covid-19 patients.
Clinical trials were conducted at KGMU, Lucknow; DMIMS, Wardha and BMC Covid Centre, Mumbai, involving 70 participants in each arm. Dr Chopra said Ayush 64 as an adjunct to standard of care (SoC) showed significant improvement and thus lesser period of hospitalisation compared to the only SoC procedure, Dr Arvind Chopra, directo ....

Uttar Pradesh , Arvind Chopra , Bhushan Patwardhan , Centre For Rheumatic Diseases , Institute Of Medical Education Research , Department Of Health Research , National Task Force On Covid , Development Task Force On Covid , Ayush Research , Covid Centre , Ayurvedic Sciences , Ministry Of Ayush , Central Council For Research , Council Of Scientific , Indian Council Of Medical Research , Government Medical College , Datta Meghe Institute Of Medical Sciences , King George Medical University , National Clinical Management Protocol , Industrial Research , Central Council , Rheumatic Diseases , Inter Disciplinary Ayush Research , Development Task Force , Health Research , Director General ,

All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases


All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases
AYUSH-64 can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said.
Share
Updated: May 3, 2021, 08:08 PM IST
AYUSH-64, a drug developed for curing malaria in 1980, can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said on Thursday.
Central Council for Research in Ayurvedic Sciences (CCRAS) recently concluded clinical trials of the drug focusing on the management of asymptomatic, mild to moderate COVID-19 in collaboration with the Council of Scientific and Industrial Research (CSIR) and other research organizations and medical colleges across the country. ....

Uttar Pradesh , Arvind Chopra , Centre For Rheumatic Diseases , Council Of Scientific , A Press Conference , Datta Meghe Institute Of Medical Sciences , National Task , King George Medical University , National Clinical Management Protocol , Ayurvedic Sciences , Ministry Of Ayush , Central Council For Research , Industrial Research , Press Conference , Rheumatic Diseases , King George , Medical University , Datta Meghe Institute , Medical Sciences , National Task Force , உத்தர் பிரதேஷ் , அரவிந்த் சோப்ரா , மையம் க்கு வாத நோய்கள் , சபை ஆஃப் அறிவியல் , தத்தா மேகே நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , தேசிய பணி ,

Researchers to study Indomethacin's impact on oxygen need in Covid patients


Researchers to study Indomethacin’s impact on oxygen need in Covid patients
April 28, 2021
×
After seeing encouraging results in a pilot study done last year, Indian researchers are now planning to conduct a randomised control trial (RCT) to understand the efficacy and safety of indomethacin in providing faster symptomatic relief and reduction in oxygen requirement in Covid-19 patients.
Indomethacin is a nonsteroidal, anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, stiffness, and swelling caused by rheumatoid arthritis.
In December 2020, Medrxiv published a preprint of a study conducted by a group of doctors, who advanced the case use of Indomethacin for faster symptomatic relief and preventing progression of pneumonia in Covid-19 patients. ....

Tamil Nadu , Andhra Pradesh , Cr Krishna Kumar , Rajan Ravichandran , Datta Meghe Institute Of Medical Sciences , Department Of Engineering Design , Indian Council For Medical Research , Narayana Medical College , Profr Krishna Kumar , Engineering Design , Datta Meghe Institute , Medical Sciences , Indian Council , Medical Research , Randomised Control Trial , Indomethacins Impact On Oxygen Need , Covid Patients , தமிழ் நாடு , ஆந்திரா பிரதேஷ் , ர் கிருஷ்ணா குமார் , ராஜன் ரவிச்சந்திரன் , தத்தா மேகே நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , துறை ஆஃப் பொறியியல் வடிவமைப்பு , இந்தியன் சபை க்கு மருத்துவ ஆராய்ச்சி , நாராயணா மருத்துவ கல்லூரி , பொறியியல் வடிவமைப்பு ,